Humana (HUM)
(Delayed Data from NYSE)
$350.83 USD
+0.51 (0.15%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $351.04 +0.21 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
HUM 350.83 +0.51(0.15%)
Will HUM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HUM
Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat
Humana (HUM) Q2 Earnings Beat on Medicare Advantage Strength
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics
Humana (HUM) Surpasses Q2 Earnings and Revenue Estimates
Can Humana (HUM) Navigate Rising Expenses in Q2 Earnings?
Other News for HUM
The U.S. uninsured rate hits 8%, a post-pandemic high
LONDON MARKET CLOSE: Stocks make modest gains as calm returns
Hummingbird Resources (HUM) Receives a Buy from Canaccord Genuity
AIM WINNERS & LOSERS: Hummingbird falls on mining challenges
Hummingbird Resources Navigates Q2 Challenges